Wang et al. [21] demonstrated that miR-145 suppresses HCC by downregulating insulin receptor substrate-1 (IRS1) and inhibiting the downstream AKT/FOXO1 signaling. Here, FOXO1 is linked to hepatocellular carcinoma.